Circulating tumor DNA (ctDNA) testing for recurrence and treatment response monitoring in hepatocellular carcinoma (HCC)

被引：0
|
作者：
Abdelrahim, M. [1 ]
Mejia, A. [2 ]
Esmail, A. [3 ]
Ouf, M. [4 ]
Franses, J. W. [5 ]
Bhan, I. [6 ]
Sudha, K. [7 ]
Brdiges, C. [8 ]
Tin, T. [9 ]
Brewer, C. [8 ]
Aushev, V. [10 ]
Palsuledesai, C. C. [8 ]
Jurdi, A. [8 ]
Liu, M. C. [11 ]
Ghobrial, R. M. [12 ]
He, A. R. [13 ]
机构：
[1] Houston Methodist Canc Ctr, Gastrointestinal Oncol, Houston, TX USA
[2] Methodist Dallas Med Ctr, Liver Inst, Dallas, TX USA
[3] Houston Methodist Neal Canc Ctr, Gastrointestinal Oncol, Houston, TX USA
[4] Georgetown Univ, GI Oncol, Med Ctr, Washington, DC USA
[5] Univ Chicago, Gastrointestinal Oncol, Chicago, IL USA
[6] Harvard Med Sch, Massachusetts Gen Hosp, Gastrointestinal Oncol, Canc Ctr, Boston, MA USA
[7] Houston Methodist, Oncol, Houston, TX USA
[8] Natera Inc, Oncol, San Carlos, CA USA
[9] Natera, R&D, San Carlos, CA USA
[10] Natera Inc, Translat Oncol, San Carlos, CA USA
[11] Natera Inc, Dept Oncol, San Carlos, CA USA
[12] Houston Methodist, Liver Inst, Houston, TX USA
[13] Georgetown Univ, Ctr Comprehens Canc, Washington, DC USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.190
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
181P
引用
收藏
页码：S82 / S82
页数：1
相关论文
共 50 条
  • [1] Personalized circulating tumor DNA (ctDNA) monitoring for recurrence detection and treatment response assessment in hepatocellular carcinoma (HCC)
    Abdelrahim, M.
    Esmail, A.
    He, A. R.
    Franses, J.
    Bhan, I.
    Victor, D. W.
    Kodali, S.
    Connor, A. A.
    Saharia, A.
    Brdiges, C.
    Tin, T.
    Brewer, C.
    Jurdi, A.
    Liu, M. C.
    Ghobrial, R. M.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S600 - S600
  • [2] Mutation profiles in circulating tumor DNA (ctDNA) to predict the efficacy of sorafenib treatment in patients with advanced hepatocellular carcinoma (HCC).
    Yang, Ping
    Ji, Guanghui
    Jiang, Qionghui
    Lu, Zejun
    Yu, Yao
    Yang, Yadong
    Jin, Ge
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Longitudinal and personalized detection of circulating tumor DNA (ctDNA) for monitoring efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma (HCC).
    Hsu, Chih-Hung
    Lu, Shan
    Abbas, Alex
    Guan, Yinghui
    Zhu, Andrew X.
    Aleshin, Alexey
    Lee, Kyung-Hun
    Lee, Michael Sangmin
    Mahipal, Amit
    Ryoo, Baek-Yeol
    Ding, Beiying
    Spahn, Jessica
    Verret, Wendy
    He, Aiwu Ruth
    Wang, Yulei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Personalized circulating tumor DNA testing for recurrence detection and treatment response monitoring in patients with metastatic invasive lobular carcinoma
    Oesterreich, Steffi
    Tin, Antony
    Rivero-Hinojosa, Samuel
    Fielder, Janie
    Ferguson, Jenifer
    Kalashnikova, Ekaterina
    Rodriguez, Angel
    Liu, Minetta
    Lee, Adrian
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [5] Feasibility of personalized and tumor informed ctdna testing for recurrence monitoring in post-transplantation hepatocellular carcinoma
    Abdelrahim, M.
    Esmail, A.
    Saharia, A.
    McMillan, R.
    He, A. R.
    Starr, J.
    Dhani, H.
    Aushev, V.
    Malashevich, A. Koyen
    Hook, N.
    Gauthier, P.
    Billings, P.
    Rodriguez, A.
    Ghobrial, R. M.
    [J]. TRANSPLANTATION, 2022, 106 (8S) : 161 - 162
  • [6] Feasibility of circulating tumor DNA testing in hepatocellular carcinoma
    Mody, Kabir
    Kasi, Pashtoon Murtaza
    Yang, Ju Dong
    Surapaneni, Phani Keerthi
    Ritter, Ashton
    Roberts, Ali
    Nagy, Rebecca
    Borad, Mitesh J.
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (04) : 745 - 750
  • [7] Hepatocellular carcinoma (HCC): Monitoring of tumour response to treatment
    不详
    [J]. EUROPEAN RADIOLOGY, 1997, 7 (08) : B11 - B11
  • [8] Serial circulating tumor DNA (ctDNA) monitoring to predict response to treatment in metastatic gastrointestinal cancers
    Parikh, A.
    Kanter, K.
    Mojtahed, A.
    Schneider, J.
    Van Seventer, E.
    Fish, M.
    Allen, J.
    Blaszkowsky, L.
    Wo, J.
    Clark, J.
    Giantonio, B.
    Goyal, L.
    Hong, T.
    Nipp, R.
    Roeland, E.
    Weekes, C.
    Zhu, A.
    Ryan, D.
    Fetter, I.
    Horick, N.
    Corcoran, R.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [9] Circulating tumor DNA (ctDNA) correlates closely with tumor necrosis and relapsefree survival (RFS) in hepatocellular carcinoma (HCC) patients treated with perioperative cemiplimab
    Marron, Thomas U.
    Brennan, Laura
    Hamon, Pauline
    Fiel, Maria Isabel
    Ward, Stephen C.
    Zhu, Yuan O.
    Kim, Edward
    Kamphorst, Alice O.
    Thanigaimani, Pradeep
    Uldrick, Thomas S.
    Lucas, Natalie
    Wu, Kathy
    Hapanowicz, Olivia
    King, Paula
    Li, Siyu
    Miller, Elizabeth
    Bhardwaj, Nina
    Thurston, Gavin
    Lowy, Israel
    Gnjatic, Sacha
    Schwartz, Myron E.
    Jankovic, Vladimir
    Merad, Miriam
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [10] Circulating tumor cell capture in hepatocellular carcinoma (HCC)
    Rochefort, Holly
    El-Khoueiry, Anthony B.
    To, Christina Ann
    Xu, Yucheng
    Xu, Tong
    Tsao-Wei, Denice
    Groshen, Susan G.
    Wei, Jenny
    Kossari, Niloofar
    Alexopoulos, Sophocils
    Goldkorn, Amir
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345